MedTrace Logo

Hepatitis C Virus (HCV) Positive Liver Grafts in HCV Negative Recipients

NCT03650920 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2022-03-18

No results posted yet for this study

Summary

To provide proof-of-concept data on the efficacy/safety of transplanting HCV positive donor grafts in HCV sero-negative liver recipients who are currently listed.

Conditions

  • Liver Failure

Interventions

PROCEDURE

Liver Transplantation

A HCV negative or previously successfully treated recipient with a HCV positive liver graft

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Michael L Volk, MD · Loma Linda University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-02
Primary Completion
2021-02-19
Completion
2021-02-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03650920 on ClinicalTrials.gov